基蛋生物
(603387)
| 流通市值：42.85亿 | | | 总市值：42.85亿 |
| 流通股本：5.07亿 | | | 总股本：5.07亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 820,157,752.94 | 555,336,020.64 | 267,501,249.08 | 1,051,714,310.24 |
| 营业总成本 | 628,168,087.45 | 410,667,258.04 | 192,223,993.5 | 797,401,359.97 |
| 其他经营收益 | | | | |
| 营业利润 | 259,501,837.22 | 205,933,989.14 | 81,202,070.54 | 231,019,922.99 |
| 利润总额 | 257,368,757.88 | 204,739,157.81 | 80,888,077.56 | 227,691,536.62 |
| 净利润 | 230,804,192.94 | 183,737,882.85 | 73,240,258.85 | 211,920,399.66 |
| 每股收益 | | | | |
| 其他综合收益 | -655,269.45 | -515,290.71 | -239,372.51 | -325,162.65 |
| 综合收益总额 | 230,148,923.49 | 183,222,592.14 | 73,000,886.34 | 211,595,237.01 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,466,867,248.97 | 2,560,677,519.52 | 2,318,369,764.71 | 2,302,677,954.01 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,230,764,141.91 | 1,209,221,368.25 | 1,380,473,371.06 | 1,453,254,420.19 |
| 资产总计 | 3,697,631,390.88 | 3,769,898,887.77 | 3,698,843,135.77 | 3,755,932,374.2 |
| 流动负债: | | | | |
| 流动负债合计 | 643,083,422.99 | 681,000,687.05 | 722,363,079.43 | 855,170,765.23 |
| 非流动负债: | | | | |
| 非流动负债合计 | 43,713,290.54 | 43,232,711.65 | 43,315,921.88 | 41,380,856.68 |
| 负债合计 | 686,796,713.53 | 724,233,398.7 | 765,679,001.31 | 896,551,621.91 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,905,790,532.08 | 2,939,572,921.79 | 2,829,581,087.07 | 2,752,734,719.8 |
| 股东权益合计 | 3,010,834,677.35 | 3,045,665,489.07 | 2,933,164,134.46 | 2,859,380,752.29 |
| 负债和股东权益合计 | 3,697,631,390.88 | 3,769,898,887.77 | 3,698,843,135.77 | 3,755,932,374.2 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 983,108,316.71 | 648,437,851.19 | 329,952,805.82 | 1,233,652,015.53 |
| 经营活动现金流出小计 | 697,755,416.8 | 459,826,259.56 | 257,278,346.78 | 841,059,316.75 |
| 经营活动产生的现金流量净额 | 285,352,899.91 | 188,611,591.63 | 72,674,459.04 | 392,592,698.78 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 987,863,544.84 | 851,049,352.93 | 232,636,525.05 | 659,276,292.79 |
| 投资活动现金流出小计 | 855,737,039.25 | 756,942,040.13 | 277,649,112.93 | 874,040,383.16 |
| 投资活动产生的现金流量净额 | 132,126,505.59 | 94,107,312.8 | -45,012,587.88 | -214,764,090.37 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 335,975,813.18 | 294,975,813.18 | 179,975,813.18 | 779,499,218.74 |
| 筹资活动现金流出小计 | 708,024,288.41 | 515,256,912.95 | 262,368,450.93 | 991,059,872.52 |
| 筹资活动产生的现金流量净额 | -372,048,475.23 | -220,281,099.77 | -82,392,637.75 | -211,560,653.78 |
| 汇率变动对现金及现金等价物的影响 | -8,004,811.27 | -5,714,488.66 | -2,407,910.58 | -7,389,626.89 |
| 现金及现金等价物净增加额 | 37,426,119 | 56,723,316 | -57,138,677.17 | -41,121,672.26 |
| 期末现金及现金等价物余额 | 346,587,012.98 | 365,884,209.98 | 252,022,216.81 | 309,160,893.98 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 56,723,316 | - | -41,121,672.26 |